🔗 Share this article

Medical professionals from Scotland and the United States have accomplished what is thought of as a world-first brain operation using a robot.

Prof Iris Grunwald, from a Scottish university, executed the remote thrombectomy - the extraction of vascular blockages after a brain attack - on a donated body that had been donated to medical science.

The professor was working from a treatment center in the Scottish city, while the specimen being treated while using the device was at another location at the academic institution.

Later that day, a neurosurgeon from the US location used the system to conduct the initial intercontinental procedure from his American facility on a human body in the Scottish city over 4,000 miles away.

The research collective has labeled it a potential "transformative advancement" if it becomes approved for clinical application.

The doctors believe this innovation could change cerebral healthcare, as a delay in accessing professional intervention can have a direct impact on the recovery prospects.

"The experience was we were observing the early preview of the coming era," commented the lead researcher.

"Where previously this was thought to be science fiction, we showed that every step of the surgery can currently be accomplished."

The medical research center is the international education hub of the global medical association, and is the exclusive site in the Britain where surgeons can treat cadavers with human blood flowing through the blood pathways to simulate procedures on a live human.

"This represented the pioneering moment that we could execute the whole mechanical thrombectomy procedure in a real human body to prove that every phase of the operation are feasible," explained the primary researcher.

A charity executive, the head of a medical organization, labeled the transatlantic procedure as "a remarkable innovation".

"During many years, residents of countryside locations have been limited in obtaining to surgical intervention," she continued.

"Robotics like this could rebalance the inequity which persists in stroke treatment across the UK."

How does the technology work?

An ischaemic stroke happens when an vascular pathway is clogged by a obstruction.

This interrupts circulation and oxygenation to the neural matter, and neurons lose function and die.

The best treatment is a surgical extraction, where a surgeon uses surgical tools to remove the clot.

But what occurs when a person can't get to a professional who can conduct the operation?

Prof Grunwald stated the trial proved a mechanical device could be linked with the identical medical instruments a surgeon would typically employ, and a medic who is with the patient could readily join the instruments.

The surgeon, in a separate site, could then manipulate and control their personal instruments, and the mechanical device then carries out exactly the same movements in immediate sequence on the individual to perform the clot removal.

The subject would be in a treatment center, while the specialist could conduct the procedure via the advanced machine from any place - even their private dwelling.

Prof Grunwald and the neurosurgeon could see live X-rays of the subject in the trials, and track developments in immediate feedback, with the lead researcher saying it took just a brief period of preparation.

Technology companies Nvidia and Ericsson were involved in the research to ensure the connectivity of the mechanical device.

"To conduct procedures from the America to Britain with a 120 millisecond lag - a blink of an eye - is absolutely amazing," commented the neurosurgeon.

The future of stroke treatment

The lead researcher, who has received recognition for her research and is also the executive member of the World Federation for Interventional Stroke Treatment, explained there were key issues with a conventional clot removal - a global shortage of surgeons who can do it, and care is determined by your location.

In Scotland, there are merely three sites patients can obtain the treatment - urban centers. If you reside elsewhere, you must travel.

"The intervention is very time sensitive," stated the lead researcher.

"Each six-minute postponement, you have a one percent reduced probability of having a positive result.

"This innovation would now deliver a new way where you're independent of where you live - conserving the crucial moments where your neural tissue is otherwise dying."

Healthcare information indicated there were {9,625 ischaemic strokes|numerous cerebral events|